Where plaintiffs showed that their federal and state antitrust claims against Johnson & Johnson satisfied all of the ...
The hospital lobby has filed a lawsuit seeking to block the federal government’s 340B Rebate Model Pilot Program, which is ...
India's nuclear energy contribution is only 3% of its energy demand, far below France's 67%. A parliamentary panel highlighted project delays, insufficient funding for research at BARC, and financial ...
The order followed the company’s assurance that it would not market any anti-obesity products in India until the patent ...
The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...
We came across a bullish thesis on BioMarin Pharmaceutical Inc. on Value investing subreddit by BearWithMeGM. In this article ...
LONDON, Dec 11 (Reuters) - Hospitals in Britain are facing a "worst case scenario" from a wave of super flu, healthcare ...
Lawyer and human rights advocate Lorenzo “Erin” Tañada III welcomed the Professional Regulatory Commission (PRC) Board of ...
LOS ANGELES, Nov. 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against aTyr Pharma Inc. ...
A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that ...
SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ -- Global plaintiffs' rights law firm Hagens Berman reminds investors of the December 8, 2025, deadline to move the Court for appointment as lead plaintiff in ...
or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback